A detailed history of Cognios Beta Neutral Large Cap Fund, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Cognios Beta Neutral Large Cap Fund, LP holds 1,809 shares of LLY stock, worth $1.44 Million. This represents 1.89% of its overall portfolio holdings.

Number of Shares
1,809
Previous 1,809 -0.0%
Holding current value
$1.44 Million
Previous $1.05 Million 33.49%
% of portfolio
1.89%
Previous 1.42%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$350.74 - $468.98 $151,519 - $202,599
-432 Reduced 19.28%
1,809 $848,000
Q1 2023

May 02, 2023

SELL
$310.63 - $364.82 $118,039 - $138,631
-380 Reduced 14.5%
2,241 $769,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $842,782 - $982,010
2,621 New
2,621 $959 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cognios Beta Neutral Large Cap Fund, LP Portfolio

Follow Cognios Beta Neutral Large Cap Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cognios Beta Neutral Large Cap Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cognios Beta Neutral Large Cap Fund, LP with notifications on news.